Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Ophthalmic Consultants of Boston · Duke Medical Center · +20 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
423
total citations
- FWCI
- 111.45
- Percentile
- 100%
- References
- 28
Citations per year
Authors
261Topics & keywords
Topics
Keywords
- Medicine
- Macular degeneration
- Population
- Geographic atrophy
- Clinical endpoint
- Clinical trial
- Atrophy
- Ophthalmology
UN Sustainable Development Goals
- Quality Education
No related works found for this paper.